Intensive investigation of the pathophysiology of axonal transport continues, emphasizing the model and sensory neuropathy induced in rats by systemic treatment with p-bromophenylacetylurea (BPAU). Results obtained during the previous funding period show that BPAU neuropathy is associated with abnormalities in the turnaround and recirculation of endogenous proteins by rapid retrograde transport. These findings are significant because turnaround-defects could cause the distal tubulomembranous axonal lesions that characterize BPAU neuropathy. Furthermore, the turnaround-abnormality occurs before other signs of nerve damage and is commensurate with the severity of the pathology. Current results show that BPAU causes another striking effect in motor nerve cells, namely a marked shortening in the onset of rapid transport. We will test the hypothesis that the shortened transport-onset reflects a disturbance in the processing of particles being assembled for delivery into the axon. Three groups of experiments are planned. First we intend to determine whether the onset-effect is uniquely caused by the neurotoxic ureides related to BPAU and to discover whether the dose-effect is uniquely caused by the neurotoxic ureides related to BPAU and to discover whether the dose-effect relations are compatible with a pathogenic role. These experiments make use of a series of BPAU analogues, locally synthesized for the purpose. The second set of experiments will analyze in detail the effect of BPAU on the kinetics of particle transport and transport-turnaround. This work takes advantages of recent advances in optical methods and image-processing for real-time analysis of particle motion. The third set of experiments will explore the possibility that BPAU treatment leads to detectable changes in the biochemical and immunochemical properties of fast transported organelles. This work involves the application of a set of monoclonal antibodies generated in this laboratory to the surface antigens of intra- axonal organelles from rat nerve. Overall we expect to add significantly to understanding of the pathogenesis of toxicant- induced, dying-back neuropathies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS018170-09
Application #
3398239
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1982-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
9
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Brailoiu, Eugen; Hoard, Jennifer L; Filipeanu, Catalin M et al. (2005) Nicotinic acid adenine dinucleotide phosphate potentiates neurite outgrowth. J Biol Chem 280:5646-50
Chiappa, S; Padilla, S; Koenigsberger, C et al. (1995) Slow accumulation of acetylcholinesterase in rat brain during enzyme inhibition by repeated dosing with chlorpyrifos. Biochem Pharmacol 49:955-63
Wu, S Y; Dun, N J (1995) Calcium-activated release of nitric oxide potentiates excitatory synaptic potentials in immature rat sympathetic preganglionic neurons. J Neurophysiol 74:2600-3
Brimijoin, S; Moser, V; Hammond, P et al. (1993) Death of intermediolateral spinal cord neurons follows selective, complement-mediated destruction of peripheral preganglionic sympathetic terminals by acetylcholinesterase antibodies. Neuroscience 54:201-23
Rakonczay, Z; Hammond, P; Brimijoin, S (1993) Lesion of central cholinergic systems by systemically administered acetylcholinesterase antibodies in newborn rats. Neuroscience 54:225-38
Brat, D J; Brimijoin, S (1993) Acrylamide and glycidamide impair neurite outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bidirectional transport of organelles observed by video microscopy. J Neurochem 60:2145-52
Brat, D J; Windebank, A J; Brimijoin, S (1992) Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma. J Pharmacol Exp Ther 261:803-10
Oka, N; Brimijoin, W S (1992) Tubulomembranous lesions in p-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: evidence from electron microscopic autoradiography. Mayo Clin Proc 67:341-8
Brat, D J; Brimijoin, S (1992) A paradigm for examining toxicant effects on viability, structure, and axonal transport of neurons in culture. Mol Neurobiol 6:125-35
Brimijoin, S; Lennon, V A (1990) Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc Natl Acad Sci U S A 87:9630-4

Showing the most recent 10 out of 21 publications